PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

How to create aqueous 100 nm-sized materials with polycavities

2025-06-02
(Press-News.org)

While molecues with a single cavity have been extensively studied in solution, the solution state functions of polycavity materials remain elusive owing to their synthetic inaccessibility. Porous aromatic polymers (PAPs) are synthesized in a single step and offer polymeric cavity frameworks with high stability, which are applicable to gas and molecule adsorption/separation only in the solid state. Due to their strong aggregation-derived insoubility, unsubstituted PAPs cannot be used in any solvent until now.

To move the functions of PAPs from the solid to the solution state, researchers from Science Tokyo's Laboratory for Chemistry and Life Science in Japan studied the solubilization of PAPs in water through encapsulation by aromatic micelles. Published in Chem (Cell Press) on June 02, Shinji Aoyama, Lorenzo Catti, and Michito Yoshizawa report that aromatic micelles, formed from bent aromatic amphiphiles (AA), are capable of solubilizing unsubstituted PAPs in water, with more than 7-times efficiency compared to conventional alkyl micelles. The solubilization was achieved using a simple grinding-sonication protocol. Detailed analyses in both solution and solid states revealed that the products exist as spherical particles with diameters of around 100 nm.

While PAPs are obtained as a complex mixture of various particle sizes during synthesis, the group demonstrated size-separation of the giant aqueous materials using a facile centrifugation-filtration protocol, yielding products with a highly uniform size-distribution. A regulated particle size is considered important for potential applications in advanced functional materials.

Importantly, PAPs within aromatic micelles effectively incorporated hydrocarbons (e.g., cyclodecane and toluene) in water. For example, stirring a mixture of an encapsulated pyrene-benzene-based PAP (PBP) with cyclodecane gave rise to a three-component material, including a huge amount of the cyclodecane molecules in the semi-rigid polycavities, showing a 9-fold enhanced polymer emission.

“Besides hydrocarbons, fluorescent organic dyes could likewise be incorporated into the polycavity yielding aqueous three-component materials with red and green emission properties. Fluorescent analysis indicated that the incorporated dyes are present in a highly dispersed fashion, unlike in related monocavity systems. Introducing completely insoluble dyes like sexithiophene into the polycavities of insoluble materials using the present method will allow the preparation of previously  inaccessible multi-component materials”, says Dr. Catti. 

Finally, the group revealed that the emission of the incorporated dyes can be significantly enhanced through co-incorporation of the hydrocarbons into the dye-doped polycavity in water. For instance, addition of cyclodecane induced a 9-fold increase in dye-based red emission, likely due to the reduction of dye-to-polymer and dye-to-dye interactions by the bulky additives. It is noteworthy that the selevtive formation of four-component materials such as the present one is extremely rare. 

The team concludes “encapsulation of 100 nm-sized porous aromatic polymers by aromatic micelles provides a new type of giant polycavity material with excellent incorporation functions in water, completely different from monocavity molecules reported previously, enabling the preparation of rare multi-component materials. The herein reported method will also be applicable to inorganic and organic-inorganic porous solids, paving the way for superior materials tailored for storage, sensing, and catalytic applications in water.”

 

***

About Institute of Science Tokyo

Institute of Science Tokyo was established on October 1, 2024, following the merger between Tokyo Medical and Dental University (TMDU) and Tokyo Institute of Technology (Tokyo Tech), with the mission of “Advancing science and human well-being to create value for and with society.”

END



ELSE PRESS RELEASES FROM THIS DATE:

Epilepsy is more common in patients with frontotemporal dementia than expected

2025-06-02
According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common than previously known. The discovery deepens understanding of the symptoms of this memory disorder and emphasises the importance of taking epileptic seizures into account in the treatment and monitoring of patients.   Coordinated by Neurocenter Finland, this major project by the University of Eastern Finland and the University of Oulu examined the prevalence of epilepsy in patients with FTD. The research dataset ...

Pre-operative THP leads to a pCR in two-thirds of early-stage HER2+ ER- breast cancer patients

2025-06-02
Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is currently being evaluated in the CompassHER2 pCR trial (EA1181, NCT04266249) by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). While longer follow-up is needed to assess long-term outcomes, pathologic complete response (pCR) rates and predictors of ...

Immune system discovery reveals potential solution to Alzheimer’s

2025-06-02
A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer’s and other neurodegenerative diseases. University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts to fix DNA damage in the brain. Their research reveals that an immune molecule called STING drives the formation of the harmful plaques and protein ...

Salamanders suffering from rising temperatures

2025-06-02
FRANKFURT. Habitat loss, diseases, pollution, and climate change are already massively affecting amphibians – frogs, salamanders, and the caecilians native to tropical regions. The new study from the Institute for Ecology, Evolution and Diversity shows that extreme weather events serve as an additional stress factor, further intensifying this crisis. For this purpose, the scientists analyzed global weather data from the past 40 years. They compared regions with significantly increased heat waves, droughts, and cold spells with the geographical ...

It’s not too late to start eating better for your brain

2025-06-02
As the U.S. population ages and dementia cases rise, many people are asking whether it is possible to prevent this devastating disease. According to a new study, the answer may be on your plate: People who followed a dietary pattern known as the MIND diet were significantly less likely to develop Alzheimer’s disease or related forms of dementia.   The MIND diet, which stands for Mediterranean-DASH Intervention for Neurodegenerative Delay, combines the Mediterranean diet with the blood pressure-lowering DASH (Dietary Approaches to Stop Hypertension) diet and also emphasizes proven brain-healthy ...

Study finds seniors are money savvy – until dementia sets in

2025-06-02
Older adults are quite aware of their financial abilities – and these abilities actually improve with age – that is, until dementia sets in, according to new research from Binghamton University, State University of New York. From paying bills to making change, knowing how to handle money is necessary to live and thrive in society. But what happens as we get older? Do our financial abilities decline and if so, are we even aware of our own shortcomings? To examine this, a team of researchers led by Binghamton University psychologist ...

Synthetic compound shows promise against multidrug resistance

2025-06-02
Highlights: Infections by antimicrobial resistant (AMR) pathogens are a leading cause of death worldwide, with more than 1 million deaths annually, highlighting the need for new treatments. Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens. Infuzide works against known, problematic gram-positive pathogens. In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.  Washington, D.C.—Antimicrobial ...

Researchers recreate ancient Egyptian blues

2025-06-02
PULLMAN, Wash.--A team of Washington State University-led researchers has recreated the world's oldest synthetic pigment, called Egyptian blue, which was used in ancient Egypt about 5,000 years ago. Reporting in the journal, NPJ Heritage Science, the researchers used a variety of raw materials and heating times to develop 12 recipes for the pigments, providing useful information for archaeologists and conservation scientists who study the ancient Egyptian materials. The work was done in collaboration with Carnegie Museum of ...

Immunotherapy before surgery improves lung cancer survival in global clinical trial led by Irish cancer specialist

2025-06-02
Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved long term survival compared to those who received chemotherapy alone, at 5 years after completing treatment.  Prof. Patrick Forde of the Trinity St. James’s Cancer Institute (TSJCI), Trinity College Dublin School of Medicine presented the findings at the American ...

S2302 Pragmatica-Lung reports out as model for faster, leaner, more representative trials

2025-06-02
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary question, finding that the investigational combination it tested did not significantly extend overall survival compared to standard of care treatments.  Importantly, the phase 3 trial’s rapid development and implementation, coupled with its successful enrollment of a group of patients broadly representative of the larger U.S. population, establish Pragmatica-Lung as a paradigm-shifting model for the design and conduct of future large randomized studies. Results will be presented ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] How to create aqueous 100 nm-sized materials with polycavities